InvestorsHub Logo

Longpicker

02/20/21 2:35 AM

#347631 RE: DrBones #347628

This article states that trials are presently on going.

CallMeCrazy

02/20/21 4:06 AM

#347637 RE: DrBones #347628

Nice find. Here's another important point lost on those who think Leo should sell or accept a buy out for a few dollars a share:

... extensive preclinical research on Kevetrin shows the re-activation of p53 across a wide spectrum of cancer lines including colon, lung, breast and pancreatic cancers. The market potential for Kevetrin in treating drug-resistant cancers is worth $5 billion a year. Other cancers could easily represent an additional $5 billion annually,... emohasis added


https://microcapdaily.com/swift-rise-of-biotech-ipix-innovation-pharmaceuticals-as-potent-therapeutic-brilacidin-begins-clinical-trials/130534/